Sanofi Reportedly Considers Acquisitions Of U.S. Biotechnology Companies

(RTTNews) - Sanofi (SNYNF, SNY) is considering potential acquisitions of U.S. biotechnology companies including Principia Biopharma as it seeks treatments for clinical areas including multiple sclerosis and immune disorders, Bloomberg reported citing people familiar with the matter.

Sanofi is working with advisers to study potential deals, the report said.

Sanofi could spend as much as $50 billion on acquisitions after announcing the disposal of its stake in Regeneron Pharmaceuticals Inc., Bloomberg reported in May.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.